Locations:
Search IconSearch

No. 2 Medical Innovation for 2020: Expanded Use of Minimally Invasive Mitral Valve Surgery

FDA makes MitraClip available to more patients with mitral regurgitation

Since 2013, minimally invasive surgery for mitral valve repair has been available for patients with primary mitral regurgitation who can’t have open heart surgery. The innovative transcatheter MitraClip® device can bring relief to patients without the risk of conventional surgery.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Just five years later, researchers in the COAPT trial reported that MitraClip repair also showed significant benefits for patients with symptomatic mitral regurgitation secondary to heart failure. The transcatheter repair device reduced all-cause mortality and hospitalization compared with medical therapy.

In response, the FDA recently broadened its approval of the device, making minimally invasive repair an option for more people with mitral regurgitation.

In this video, learn more about why expanded use of minimally invasive mitral valve surgery is one of Cleveland Clinic’s Top 10 Medical Innovations for 2020.

Expanded Use of Minimally Invasive Mitral Valve Surgery

Advertisement

Related Articles

Photo of Tom Mihaljevic, MD, and Gary Cohn
A Fireside Chat about Digital Technology in Healthcare

Cleveland Clinic and IBM leaders share insights, concerns, optimism about impacts

23-CCC-4375920 Zipline drone delivery 650×450
Delivering Drugs via Drone

Cleveland Clinic will offer rapid, pinpoint airborne transport of medications and other medical items

22-CCC-2742016-Hero1-650×450
Top 10 Medical Innovations for 2022 Unveiled

Next-generation mRNA vaccines are among the advancements likely to change healthcare this year

Lead paint
Why Lead Safety Has Become Cleveland Clinic’s Top Priority for Community Health

$50 million pledge will help remove sources of lead exposure from Cleveland homes

mroz-spine-surgery-219
Thomas Mroz, MD, Named Chair of the Orthopaedic & Rheumatologic Institute

The spine surgeon will oversee more than 125 staff physicians in his new role

James Merlino, MD
James Merlino, MD, Named Inaugural Chief Clinical Transformation Officer

Merlino rejoins Cleveland Clinic to help execute bold strategic vision

19-CCC-6023-top10Innov-2019-8_650x450
No. 8 Medical Innovation for 2020: Bempedoic Acid for Statin-Intolerant Patients

Reduces muscle pain caused by cholesterol-lowering drugs

19-CCC-6022-top10Innov-2019-7_650x450
No. 7 Medical Innovation for 2020: Antibiotic Envelope for Cardiac Implantable Devices

Reduces incidence of infection by 40% compared to standard of care

Ad